Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| b-Cyclodextrin-iodine inclusion complex | b-Cyclodextrin-iodine inclusion complex. Uses: Designed for use in research and industrial production. Additional or Alternative Names: B-CYCLODEXTRIN-IODINE INCLUSION COMPLEX. Product Category: Heterocyclic Organic Compound. CAS No. 61216-03-3. Molecular formula: C42H70O35.I2. Mole weight: 1388.78. Product ID: ACM61216033. Alfa Chemistry ISO 9001:2015 Certified. |  |
| b-Cyclodextrin polymer crosslinked with epichlorohydrin | b-Cyclodextrin polymer crosslinked with epichlorohydrin is an immensely multifaceted biomedical material, denoting an intriguing compound for drug delivery and encapsulation purposes. Emanating a profound affinity towards hydrophobic drugs, this polymer manifests its aptitude in orchestrating the restrained discharge of therapeutic drugs, including anti-inflammatory substances and anticancer compounds. Synonyms: Poly-beta-cyclodextrin (Cross-linked by Epichlorohydrin). |  |
| 2,3-Dimethyl-6-tert-butyldimethylsilyl-b-cyclodextrin | 2,3-Dimethyl-6-tert-butyldimethylsilyl-b-cyclodextrin, a compound widely employed in the biomedical field, plays a pivotal role in enhancing drug efficacy through its distinct structural properties. This versatile agent facilitates the solubilization and regulated release of drugs afflicted with poor solubility or instability. Its profound implications extend to formulating treatments for ailments including but not limited to cancer, cardiovascular disorders, and neurodegenerative maladies. Synonyms: 2,3-Di-O-methyl-6-O-tert-butyldimethylsilyl)cyclomaltoheptaose; Heptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-b-cyclodextrin; 6A,6B,6C,6D,6E,6F,6G-Heptakis-O-[(1,1-dimethylethyl)dimethylsilyl]-2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-tetradeca-O-methyl-β-cyclodextrin; 2,3-Di-O-methyl-6-O-tert-butyldimethylsilyl β-cyclodextrin; Heptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-β-cyclodextrin; Heptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)cyclomaltoheptaose; Heptakis(6-O-tert-butyldimethylsilyl-2,3-di-O-methyl)-β-cyclodextrin. CAS No. 123155-04-4. Molecular formula: C98H196O35Si7. Mole weight: 2131.18. | |
| 2,3-Dimethyl-b-cyclodextrin | 2,3-Dimethyl-b-cyclodextrin is a modified cyclodextrin derivative, used primarily in enhancing drug solubility for therapeutics with low water-solubility. It's often utilized in theresearch of diseases requiring complex medication formulations. Synonyms: Heptakis(2,3-di-O-methyl)-b-cyclodextrin; 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-Tetradeca-O-methyl-β-cyclodextrin; 2,3-Dimethyl-β-cyclodextrin; 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-Tetradecamethoxy-β-cyclodextrin; Heptakis(2,3-di-O-methyl)-β-cyclodextrin; Heptakis(2,3-dimethyl)-β-cyclodextrin; 2,3-DMe-beta-cyclodextrin. CAS No. 123155-05-5. Molecular formula: C56H98O35. Mole weight: 1331.36. | |
| 2,3-Di-O-acetyl-b-cyclodextrin | 2,3-Di-O-acetyl-b-cyclodextrin is a derivative of beta-cyclodextrin, used in the biomedical industry for drug delivery systems. It enhances the soluble property of poorly water-soluble drugs, aiding in their absorption and distribution. Synonyms: Heptakis-(2,3-di-O-acetyl)-b-cyclodextrin. Molecular formula: C70H98O49. Mole weight: 1723.50. | |
| 2,3-Di-O-allyl-b-cyclodextrin | 2,3-Di-O-allyl-b-cyclodextrin is a modified cyclodextrin used to enhance drug delivery. It's primarily used in pharmaceuticals to improve solubility and stability of poorly soluble drugs, facilitating more efficient drug absorption and increasing their therapeutic efficacy. Synonyms: Heptakis-(2,3-di-O-allyl)-b-cyclodextrin. Molecular formula: C84H126O35. Mole weight: 1695.88. | |
| 2,3-Di-O-benzyl-b-cyclodextrin | 2,3-Di-O-benzyl-b-cyclodextrin is a modified cyclodextrin primarily used in the pharmaceutical industry. Its unique structure increases drug solubility and stability. Synonyms: Heptakis-(2,3-di-O-benzyl)-b-cyclodextrin. Molecular formula: C140H154O35. Mole weight: 2396.70. | |
| 2,6-Diethyl-b-cyclodextrin | 2,6-Diethyl-b-cyclodextrin, an essential and widely used cyclodextrin derivative in biomedicine, serves as an effective solubilizer and stabilizer for poorly water-soluble drugs, intensifying their bioavailability and efficacy to a great extent. Additionally, recent research has shown its therapeutic potential for treating diseases, such as cancer, inflammation, and viral infections, making it an incredibly promising and crucial ingredient in the biomedicine industry. Synonyms: Heptakis-(2,6-di-O-ethyl)-b-cyclodextrin; 2A,2B,2C,2D,2E,2F,2G,6A,6B,6C,6D,6E,6F,6G-Tetradeca-O-ethyl-β-cyclodextrin; 2,6-Di-O-ethyl-β-cyclodextrin; 2,6-Diethyl-β-cyclodextrin; Heptakis(2,6-di-O-ethyl)-β-cyclodextrin. CAS No. 111689-03-3. Molecular formula: C70H126O35. Mole weight: 1527.73. | |
| (2-Carboxyethyl)-b-cyclodextrin | (2-Carboxyethyl)-b-cyclodextrin is a vital component in the biomedical industry. It is extensively used as an excipient or carrier for drugs, enabling improved drug solubility and stability. This innovative compound finds applications in targeted drug delivery systems and pharmaceutical formulations. Synonyms: CEBCD; (2-Carboxyethyl)-b-cyclodextrin sodium salt. Grade: 95%. Molecular formula: C42H70-nO35·(C2H4COONa)n. Mole weight: 1135.0+n(94.1). | |
| (2-Carboxyethyl)-b-cyclodextrin sodium salt | (2-Carboxyethyl)-b-cyclodextrin sodium salt is a pharmaceutical excipient used to enhance the solubility and stability of drugs. It's particularly effective for hydrophobic drugs, improving absorption and bioavailability. Synonyms: (2-Carboxyethyl)-beta-cyclodextrin sodium salt; (2-Carboxyethyl)-β-cyclodextrin sodium salt; CEBCD. Molecular formula: C42H70-nO35·(CH2CH2COONa)n. | |
| (2-Hydroxyethyl)-b-cyclodextrin | (2-Hydroxyethyl)-β-cyclodextrin is a derivative of β-cyclodextrin, which can help improve the solubility of the drug in oral preparations or preparations. Synonyms: Hydroxyethyl beta-cyclodextrin; B-Cyclodextrin, 2-hydroxyethyl ethers; β-Cyclodextrin, 2-hydroxyethyl ethers. CAS No. 128446-32-2. Molecular formula: C56H98O42. Mole weight: 1443.36. | |
| 6-Aminomethyl-6-deoxy-b-cyclodextrin | 6-Aminomethyl-6-deoxy-b-cyclodextrin is a versatile biomedicine tool playing an integral role in revolutionizing the field of drug delivery systems and pharmaceutical formulations. Harnessing its intricate molecular structure, this exceptional cyclodextrin derivative effectively enhances drug solubility and augments bioavailability. Synonyms: Heptakis-(6-aminomethyl-6-deoxy)-b-cyclodextrin. Molecular formula: C49H91N7O28. Mole weight: 1226.28. | |
| 6-Bromo-6-deoxy-b-cyclodextrin | 6-Bromo-6-deoxy-β-cyclodextrin, a highly versatile pharmaceutical excipient, garners immense significance in the biomedical industry. Exhibiting extraordinary capabilities as a host molecule within drug delivery systems, it remarkably ameliorates the solubility, stability, and bioavailability of diverse drugs. Synonyms: Heptakis-(6-bromo-6-deoxy)-b-cyclodextrin; 6A,6B,6C,6D,6E,6F,6G-Heptabromo-6A,6B,6C,6D,6E,6F,6G-heptadeoxy-β-cyclodextrin; 6-Bromo-6-deoxy-β-cyclodextrin; Heptakis(6-deoxy-6-bromo)-β-cyclodextrin; Heptakis(6-bromo-6-deoxy)-β-cyclodextrin. CAS No. 53784-83-1. Molecular formula: C42H63Br7O28. Mole weight: 1575.26. | |
| 6-Chloro-6-deoxy-b-cyclodextrin | 6-Chloro-6-deoxy-β-cyclodextrin is a meticulously engineered cyclodextrin derivative standing as a quintessential exemplar for drug delivery and encapsulation purposes. Its exceptional properties allow it to profoundly enhance the solubility and stability of hydrophobic drugs. Synonyms: Heptakis-(6-chloro-6-deoxy)-b-cyclodextrin. Molecular formula: C42H63Cl7O28. Mole weight: 1264.10. | |
| 6-Cyano-6-deoxy-b-cyclodextrin | 6-Cyano-6-deoxy-β-cyclodextrin is a pivotal entity with pronounced efficacy observed in augmenting solubility and stability of diverse pharmaceuticals, encompassing potent anticancer compounds and antiviral therapeutics. Synonyms: Heptakis-(6-cyano-6-deoxy)-b-cyclodextrin. Molecular formula: C49H63N7O28. Mole weight: 1198.05. | |
| 6-Deoxy-6-iodo-b-cyclodextrin | 6-Deoxy-6-iodo-b-cyclodextrin: This exceptional cyclodextrin derivative exhibits remarkable application in the realm of biomedical science. It has piqued the interest of researchers owing to its immense potential in drug delivery systems, specifically for the targeted administration of iodine-based medications. Synonyms: Heptakis-(6-deoxy-6-iodo)-b-cyclodextrin; 6A,6B,6C,6D,6E,6F,6G-Heptadeoxy-6A,6B,6C,6D,6E,6F,6G-heptaiodo-β-cyclodextrin; 6,6',6'',6''',6'''',6''''',6''''''-Heptadeoxy-6,6',6'',6''',6'''',6''''',6''''''-heptaiodo-β-cyclodextrin; Heptakis(6-deoxy-6-iodo)-β-cyclodextrin; Heptakis(6-deoxy-6-iodo)cyclomaltoheptaose; Heptakis(6-iodo-6-deoxy)-β-cyclodextrin; Per-6-iodo-β-cyclodextrin. CAS No. 30754-23-5. Molecular formula: C42H63I7O28. Mole weight: 1904.26. | |
| 6-Tert-butyldimethylsilyl-b-cyclodextrin | 6-Tert-butyldimethylsilyl-b-cyclodextrin is a versatile compound widely used in the biomedical industry. It acts as a carrier molecule for various drugs, including hydrophobic ones, improving their solubility and stability. Synonyms: Heptakis-(6-O-tert-butyldimethylsilyl)-b-cyclodextrin; 6A,6B,6C,6D,6E,6F,6G-Heptakis-O-[(1,1-dimethylethyl)dimethylsilyl]-β-cyclodextrin; 6-tert-Butyldimethylsilyl-β-cyclodextrin; Heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin; Heptakis-6-O-(dimethyl-tert-butylsilyl)-β-cyclodextrin; Hydrodex β-6TBDM. CAS No. 123155-03-3. Molecular formula: C84H168O35Si7. Mole weight: 1934.81. | |
| Carboxylated b-cyclodextrin | Carboxylated b-cyclodextrin. | |
| Heptakis-(6-azido-6-deoxy)-b-cyclodextrin | Heptakis-(6-azido-6-deoxy)-b-cyclodextrin is a biomolecule used in drug delivery and bioimaging applications. Its unique structure allows it to encapsulate or bind to guest molecules, making it an ideal candidate for drug delivery. In addition, its azide groups can be used as chemical handles for the attachment of imaging probes or targeting molecules. Synonyms: 6A,6B,6C,6D,6E,6F,6G-Heptaazido-6A,6B,6C,6D,6E,6F,6G-heptadeoxy-β-cyclodextrin; 6-Azido-6-deoxy-β-cyclodextrin; Hepta-6-azido-6-deoxy-β-cyclodextrin; Heptakis(6-azido-6-deoxy)-β-cyclodextrin; Heptakis(6-azido-6-deoxy)cyclohepta-α-1,4-glucan; Heptakis(6-deoxy-6-azido)-β-cyclodextrin; Per-(6-deoxy-6-azido)-β-cyclodextrin; Per-6-azido-6-deoxy-β-cyclodextrin; Per-6-azido-β-cyclodextrin; Perazido-β-cyclodextrin. CAS No. 53958-47-7. Molecular formula: C42H63N21O28. Mole weight: 1310.07. | |
| Hexakis-(6-O-acetyl)-b-cyclodextrin | Hexakis-(6-O-acetyl)-b-cyclodextrin is a compound used in the pharmaceutical industry to improve drug solubility and stability. It is commonly used as an excipient in formulations to enhance the delivery of poorly soluble drugs. This product has been found to be effective in studying conditions such as cancer, infections and cardiovascular diseases by enabling better absorption and bioavailability of active pharmaceutical ingredients. Synonyms: AcBCD; Acetyl-b-cyclodextrin; Monoacetyl-b-cyclodextrin; β-Cyclodextrin, 6A,6B,6C,6D,6E,6F,6G-heptaacetate. CAS No. 144307-06-2. Molecular formula: C56H84O42. Mole weight: 1429.25. | |
| 2,3-Dimethyl-cyclodextrin-6-hydrogen sulfate, sodium salt | 2,3-Dimethyl-cyclodextrin-6-hydrogen sulfate, sodium salt, a remarkably versatile compound extensively employed in the field of biomedical research, represents a paramount breakthrough. In its pivotal role as a complexing agent, it unfailingly amplifies the solubility and durability of an array of pharmaceutical compounds. This extraordinary product exhibits unparalleled efficacy when employed in the formulation of drug delivery mechanisms designed to tackle a multitude of debilitating ailments, including but not limited to cancer, cardiovascular afflictions, and neurologic disorders. Synonyms: Heptakis(2,3-di-O-methyl-6-O-sulfo)-b-cyclodextrin heptasodium salt; β-Cyclodextrin, 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-tetradeca-O-methyl-, 6A,6B,6C,6D,6E,6F,6G-heptakis(hydrogen sulfate), sodium salt (1:7); 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-Tetradeca-O-methyl-β-cyclodextrin, heptakis(hydrogen sulfate), heptasodium salt; Heptakis(2,3-di-O-methyl-6-O-sulfo)-β-cyclodextrin sodium salt; Heptakis(2,3-dimethyl-6-sulfato)-β-cyclodextrin sodium salt; Sodium heptakis(2,3-dimethyl-6-sulfato)-β-cyclodextrin. CAS No. 201346-23-8. Molecular formula: C56H91Na7O56S7. Mole weight: 2045.64. | |
| Beta-cyclodextrin phosphate sodium salt | Beta-cyclodextrin phosphate sodium salt is a pharmaceutical ingredient with applications in the biomedical industry. It acts as a drug carrier, enhancing solubility and bioavailability of poorly soluble drugs. Synonyms: b-cyclodextrin phosphate sodium salt; β-cyclodextrin phosphate sodium salt; β-Cyclodextrin, dihydrogen phosphate, sodium salt; Sodium β-cyclodextrin phosphate. CAS No. 199684-61-2. Molecular formula: C42H70O35.xH3O4P.xNa. | |
| Beta-cyclodextrin sulfate sodium salt | Beta-cyclodextrin sulfate sodium salt is an exceptional biomedical compound, exhibiting unparalleled proficiency as a carrier in drug delivery systems. Through the intricate encapsulation of pharmaceuticals, it exalts their solubility and stability, thereby facilitating optimal release. Synonyms: b-cyclodextrin sulfate sodium salt; β-cyclodextrin sulfate sodium salt; β-Cyclodextrin, hydrogen sulfate, sodium salt (1:x); Sodium salt of sulfated cycloheptaamylose. CAS No. 37191-69-8. Molecular formula: C42H70O35.xH2O4S.xNa. | |
| Cyclodextrins | Cyclodextrins occur as white, practically odorless, fine crystalline powders, having a slightly sweet taste. Some cyclodextrin derivatives occur as amorphous powders. Synonyms: Cavitron; cyclic oligosaccharide; cycloamylose; cycloglucan; Encapsin; Schardinger dextrin. Product ID: PE-0591. Category: Solubilizing Agents; Stabilizing Agents. Product Keywords: Stabilizers; Solubilizer Excipients; PE-0591; Cyclodextrins; Solubilizing Agents; Stabilizing Agents;. UNII: Z1LH97KTRM. Grade: Pharmceutical Excipients. Administration route: α-cyclodextrin (injection); β-cyclodextrin (oral; topical); γ-cyclodextrin (IV injections). Dosage Form: α-cyclodextrin (injection preparations); β-cyclodextrin (oral tablets, topical gels); γ-cyclodextrin (IV injections). Stability and Storage Conditions: β-Cyclodextrin and other cyclodextrins are stable in the solid state if protected from high humidity. Cyclodextrins should be stored in a tightly sealed container, in a cool, dry place. Source and Preparation: Cyclodextrins are manufactured by the enzymatic degradation of starch using specialized bacteria. For example, b-cyclodextrin is produced by the action of the enzyme cyclodextrin glucosyltransferase upon starch or a starch hydrolysate. An organic solvent is used to direct the reaction that produces b-cyclodextrin, and to prevent the growth of microorganisms during the enzymatic reaction. The inso |  |
| Cyclomaltoheptaose hydrate | Cyclomaltoheptaose hydrate, a cyclic oligosaccharide with vast potential for drug delivery and structural studies, has been shown to effectively inhibit the activity of various enzymes implicated in diseases such as cancer and Alzheimer's. Additionally, it displays remarkable chiral resolving properties, making it a highly useful tool for separating enantiomers. Its multifaceted nature is a valuable asset in advancing numerous scientific fields. Synonyms: b-Cyclodextrin hydrate; β-Cyclodextrin, hydrate (1:x); Cycloheptaamylose hydrate; β-Cyclodextrin hydrate; Adrabetadex hydrate; β-Cycloamylose hydrate; β-Cycloheptaamylose hydrate; β-Dextrin hydrate. CAS No. 68168-23-0. Molecular formula: C42H70O35.xH2O. Mole weight: 1134.98 (anydrous basis). | |
| Heptakis(2,3,6-tri-O-benzoyl)cyclomaltoheptaose | Heptakis(2,3,6-tri-O-benzoyl)cyclomaltoheptaose, a derivative of cyclodextrin, presents an exceptional ability to encapsulate hydrophobic molecules, endorsing solubility and bioavailability of drugs. Its innovative therapeutic applications for cancer and drug-resistant fungal infections have been extensively researched, substantiating its potential as a vanguard drug delivery system. Synonyms: Heptakis-(2,3,6-tri-O-benzoyl)-b-cyclodextrin; β-Cyclodextrin, 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6A,6B,6C,6D,6E,6F,6G-heneicosabenzoate; β-Cyclodextrin, heneicosabenzoate; Hepta-(2,3,6-tri-oxy-benzoyl)-β-cyclodextrin; Heptakis(2,3,6-tri-O-benzoyl)-β-cyclodextrin; β-Cyclodextrin perbenzoate; Tri-O-benzoyl-b-cyclodextrin; b-Cyclodextrin heptakis(2,3,6-tri-O-benzoate). CAS No. 23666-43-5. Molecular formula: C189H154O56. Mole weight: 3321.21. | |
| Heptakis(2,3,6-tri-O-ethyl)cyclomaltoheptaose | Heptakis(2,3,6-tri-O-ethyl)cyclomaltoheptaose is a biomedicine product utilized in the treatment of various drug delivery systems and targeted therapies. Its applications include encapsulating and delivering drugs specifically to treat liver diseases, cancer, and other chronic conditions. With its unique structure, this product enhances drug solubility, stability, and bioavailability, fostering effective treatment outcomes. Synonyms: Heptakis-(2,3,6-tri-O-ethyl)-b-cyclodextrin; 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6A,6B,6C,6D,6E,6F,6G-Heneicosa-O-ethyl-β-cyclodextrin; Hepta-(2,3,6-tri-oxy-ethyl)-β-cyclodextrin; Heptakis(2,3,6-tri-O-ethyl)-β-cyclodextrin; Perethylated β-cyclodextrin. CAS No. 111689-01-1. Molecular formula: C84H154O35. Mole weight: 1724.10. | |
| Heptakis(2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl)cyclomaltoheptaose | Heptakis(2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl)cyclomaltoheptaose, a highly significant compound extensively utilized in the biomedical sector, assumes a pivotal role in diverse therapeutic applications. With its remarkable capacity to effectively combat numerous afflictions, this product stands out as an indispensable entity within the realm of modern biomedical research and development. Beneath its intricately designed structure lies a potent agent capable of precisely targeting specific medications or facilitating the development of innovative drug delivery systems. Synonyms: Silyl(6-O-tert-butyldimethyl)-2,3-di-acetyl)-b-cyclodextrin; Heptakis(6-O-tert-butyldimethylsilyl)-b-cyclodextrin tetradecaacetate; β-Cyclodextrin, 6A,6B,6C,6D,6E,6F,6G-heptakis-O-[(1,1-dimethylethyl)dimethylsilyl]-, tetradecaacetate; β-Cyclodextrin, 6A,6B,6C,6D,6E,6F,6G-heptakis-O-[(1,1-dimethylethyl)dimethylsilyl]-, 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-tetradecaacetate; 2,3-Di-O-acetyl-6-O-tert-butyldimethylsilyl β-cyclodextrin; Heptakis(2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl)-β-cyclodextrin; Heptakis(6-O-tert-butyldimethylsilyl-2,3-di-O-acetyl)-β-cyclodextrin; Hydrodex β-TBDAc; Silyl((6-tert-butyl-dimethyl)-2,3-di-oxy-acetyl)-β-cyclodextrin. CAS No. 123172-94-1. Molecular formula: C112H196O49Si7. Mole weight: 2523.32. | |
| Heptakis-(2,6-di-O-tert-Butyldimethylsilyl)-beta-Cyclodextrin | Heptakis-(2,6-di-O-tert-Butyldimethylsilyl)-beta-Cyclodextrin is an excipient in drug formulation to enhance drug solubility and stability. This compound aids in the development of various diseases by improving drug delivery efficiency, particularly for poorly soluble drugs. Synonyms: Heptakis-(2,6-di-O-tert-butyldimethylsilyl)-b-cyclodextrin; 2,6-Di-TBDMS-b-cyclodextrin. CAS No. 84346-53-2. Molecular formula: C126H266O35Si14. Mole weight: 2734.64. | |
| Methyl Cyclodextrin ; beta-Cyclodextrin methylether | Methyl Cyclodextrin ; beta-Cyclodextrin methylether. Synonyms: MBC; BETA-CYD; BETA-W7 M18; METHYL B-CYCLODEXTRIN; METHYL-SS-CYCLODEXTRIN; Dimethyl-β-Cyclodextrin; METHYL-BETA-CYCLODEXTRIN; B-Cyclodextrin methyl ether; beta-cyclodextrin, methylethers. CAS No. 128446-36-6. Product ID: PE-0588. Molecular formula: C54H94O35. Mole weight: 1303.3. Category: Solubilizing Agents. Product Keywords: Excipients for Liquid Dosage Form; Solubilizer Excipients; PE-0588; Methyl Cyclodextrin ; beta-Cyclodextrin methylether; Solubilizing Agents; C54H94O35; 128446-36-6. UNII: NA. Grade: Pharmceutical Excipients. Source and Preparation: In this paper, methyl-β-cyclodextrin was prepared by using dimethyl sulfate as alkylation reagent. Add 2g sodium hydroxide and 30mL deionized water to a triangular bottle, then add 10g β-cyclodextrin, stir to dissolve. At room temperature, 5mL dimethyl sulfate was slowly added and stirred at the same time. The reaction was heated in a water bath at about 60 °C for 8h. After the reaction, it was cooled and adjusted to neutral with dilute hydrochloric acid. The collection liquid was distilled under vacuum pressure, concentrated to syrupy form, and slowly dropped into 40mL acetone. The product was dispersed into a powdery solid in the acetone. The acetone was filtered out and the product was vacuum dried. Applications: Widely used in pharmaceutical, food, | |
| Sulfobutylether β- Cyclodextrin | β-Cyclodextrin is a cyclic oligosaccharide containing seven D-(+)-glucopyranose units attached by a(1→4) glucoside bonds. Sulfobutylether b-cyclodextrin is an anionic β-cyclodextrin derivative with a sodium sulfonate salt separated from the hydrophobic cavity by a butyl spacer group. The substituent is introduced at positions 2, 3, and 6 in at least one of the glucopyranose units in the cyclodextrin structure. Synonyms: β-Cyclodextrin sulfobutylether, sodium salt; Captisol; (SBE)m-betaCD; SBE7-b-CD; SBECD; sulfobutylether-β-cyclodextrin, sodium salt. CAS No. 1824100-00-0. Product ID: PE-0597. Molecular formula: C42H70-nO35·(C4H8SO3Na)n. Mole weight: 2163 (where n = approximately 6.5). Category: Biocompatibility enhancer; Osmotic Agents; Solubilizing Agents; Stabilizing Agents; Tablet and Capsule Diluent; Viscosity-increasing Agents; Water activity reducing Agents. Product Keywords: Stabilizers; Solubilizer Excipients; PE-0597; Sulfobutylether β- Cyclodextrin; Biocompatibility enhancer; Osmotic Agents; Solubilizing Agents; Stabilizing Agents; Tablet and Capsule Diluent; Viscosity-increasing Agents; Water activity reducing Agents; C42H70-nO35·(C4H8SO3Na)n; 1824100-00-0. UNII: NA. Chemical Name: β-Cyclodextrin sulfobutylether, sodium salt. Grade: Pharmceutical Excipients. Administration route: SC, oral, inhalation, nasal and ophthalmic, IV and IM. Dosage Form: SC, ora | |
Our database is helping our users find suppliers everyday.
